All ATGC article

Approved Tumour-Agnostic Drugs

Cancer treatments usually target cancer that has developed in a specific organ or tissue, like breast or lung cancer. Tumour-agnostic therapy, also known as tissue-agnostic therapy, utilizes the same drug to treat all cancer types that have certain genetic mutations or biomarkers that are targeted by the drug.

Q & A Session

One question asked by the audience to Dr. Samatha was, “What is the possibility of preventing a lot of diseases using predictive and preventive medicine and using metabolic biomarkers at a very early stage for a lot of cases since the cost of tests after getting a disease is very expensive

Panel Discussion: 2 -Realizing the Promise of Personalized Medicine

Dr. Hima started the second panel discussion by thanking all the panelists for gracing the stage and accepting the invitation to come over and talk a little bit about personalized medicine. She introduced all the physicians who have been actively incorporating personalized medicine into their practice and saw what their perspective was on the floor and what was happening right now.